Melexis NV
MELE: XBRU (BEL)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
€269.00 | Zcmljk | Rrxgzgps |
Melexis Shares Offer Attractive 40% Upside; Decreasing Our Fair Value Estimate to EUR 100
We believe narrow-moat Melexis shares offer an attractive buying opportunity at this point. Although we are decreasing our fair value estimate to EUR 100 from EUR 105 after adjusting our medium-term forecasts, shares offer 40% upside for long-term investors who are willing to endure a few quarters of uncertainty. Melexis is trading at 13.0 times the 2022 EBIT and 11.3 times the last 12 months' EBIT.